Abstract:Reactive oxygen species (ROS) contribute to cellular redox environment and serve as signaling molecules. Excessive ROS can lead to oxidative stress that are involved in a broad spectrum of physiological and pathological conditions. Stem cells have unique ROS regulation while cancer cells frequently show a constitutive oxidative stress that is associated with the invasive phenotype. Antioxidants have been proposed to forestall tumor progression while targeted oxidants have been used to destroy tumor cells. However, the delicate beneficial range of ROS levels for stem cells and tumor cells under distinct contexts remains elusive. Here, we used Drosophila midgut intestinal stem cell (ISCs) as an in vivo model system to tackle this question. The ROS levels of ISCs remained low in comparison to that of differentiated cells and increased with ageing, which was accompanied by elevated proliferation of ISCs in aged Drosophila. Neither upregulation nor downregulation of ROS levels significantly affected ISCs, implicating an intrinsic homeostatic range of ROS in ISCs. Interestingly, we observed similar moderately elevated ROS levels in both tumor-like ISCs induced by Notch (N) depletion and extracellular matrix (ECM)-deprived ISCs induced by β-integrin (mys) depletion. Elevated ROS levels further promoted the proliferation of tumor-like ISCs while reduced ROS levels suppressed the hyperproliferation phenotype; on the other hand, further increased ROS facilitated the survival of ECM-deprived ISCs while reduced ROS exacerbated the loss of ECM-deprived ISCs. However, N- and mys-depleted ISCs, which resembled metastatic tumor cells, harbored even higher ROS levels and were subjected to more severe cell loss, which could be partially prevented by ectopic supply of antioxidant enzymes, implicating a delicate pro-surviving and proliferating range of ROS levels for ISCs. Taken together, our results revealed stem cells can differentially respond to distinct ROS levels under various conditions and suggested that the antioxidant-based intervention of stem cells and tumors should be formulated with caution according to the specific situations.

Regulation of reactive oxygen species in stem cells and cancer stem cells

Reactive Oxygen Species in Normal and Tumor Stem Cells

Predominant factors influencing reactive oxygen species in cancer stem cells

Redox homeostasis: the linchpin in stem cell self-renewal and differentiation

Roles of Reactive Oxygen Species in the Fate of Stem Cells

Reactive Oxygen Species and Mitochondrial Homeostasis as Regulators of Stem Cell Fate and Function

New Insights into Redox Regulation of Stem Cell Self-Renewal and Differentiation

Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism

Regulation of Stem Cell Fate by ROS-mediated Alteration of Metabolism

Targeting ROS in cancer: rationale and strategies

Roles of Reactive Oxygen Species in Pluripotent Stem Cell Functions

Regulation of the mitochondrial reactive oxygen species: Strategies to control mesenchymal stem cell fates ex vivo and in vivo

Controlling Cancer Cells Using Reactive Oxygen Species

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Redox Regulation of Cell Survival

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Redox control of the survival of healthy and diseased cells.

Metabolic Regulation of Redox Balance in Cancer

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?

Context-dependent responses of Drosophila intestinal stem cells to intracellular reactive oxygen species